Myelodysplastic Syndromes
Showing NaN - NaN of 34
MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)
Recruiting
- Myelodysplastic Syndromes
- Tamibarotene + Azacitidine
- Tamibarotene Matched Placebo + Azacitidine
-
Tucson, Arizona
- +87 more
Feb 2, 2023
Acute Myeloid Leukemia, MDS Trial in United States (SL-172154)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Duarte, California
- +12 more
Jan 23, 2023
MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)
Active, not recruiting
- Myelodysplastic Syndromes
- MBG453
- +2 more
-
Duarte, California
- +46 more
Jan 20, 2023
MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndromes
- Magrolimab
- +2 more
-
Birmingham, Alabama
- +168 more
Dec 7, 2022
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)
Enrolling by invitation
- Acute Myeloid Leukemia
- +2 more
-
Fountain Valley, California
- +28 more
Nov 18, 2022
Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia (AML)
- +3 more
-
Birmingham, Alabama
- +26 more
Sep 12, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- BPX-501 dose 1
- +5 more
-
Atlanta, Georgia
- +7 more
Jul 10, 2022
Acute Myeloid Leukemia, MDS, Glioblastoma Multiforme Trial in United States (DSP-7888 Dosing Emulsion)
Completed
- Acute Myeloid Leukemia
- +8 more
- DSP-7888 Dosing Emulsion
-
Denver, Colorado
- +7 more
Apr 4, 2022
MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)
Completed
- Myelodysplastic Syndromes
- Secondary Acute Myeloid Leukemia (AML)
-
Chicago, Illinois
- +5 more
Mar 15, 2022
MDS Trial in United States (Pracinostat, Azacitidine)
Terminated
- Myelodysplastic Syndromes
-
Duarte, California
- +24 more
Feb 4, 2022
Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)
Completed
- Hematologic Malignancy
- +4 more
-
Washington, District of Columbia
- +12 more
Jul 20, 2021
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
MDS Trial in Canada, United States (anti-thymocyte globulin)
Completed
- Myelodysplastic Syndromes
- anti-thymocyte globulin
-
Washington, District of Columbia
- +27 more
Jan 24, 2021
MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)
Completed
- Myelodysplastic Syndromes
- +3 more
- rigosertib sodium
-
Stanford, California
- +34 more
Jun 29, 2020
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
MDS Trial in United States (azacitidine)
Completed
- Myelodysplastic Syndromes
-
Bakersfield, California
- +30 more
Nov 7, 2019
MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in United States (oral azacitidine)
Completed
- Myelodysplastic Syndromes
- +2 more
- oral azacitidine
-
La Jolla, California
- +7 more
Nov 7, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)
Completed
- Leukemia
- +4 more
- therapeutic allogeneic lymphocytes
- +6 more
-
Denver, Colorado
- +13 more
Sep 13, 2019
Leukemia, MDS, Blastic Plasmacytoid Dendritic Cell Tumor Trial in Dallas (DT388IL3)
Completed
- Leukemia
- +2 more
-
Dallas, TexasUT Southwestern Medical Center
Mar 29, 2019
Bone Marrow and Blood Samples From Leukemia or Other
Completed
- Leukemia
- +2 more
- cytogenetic analysis
- fluorescence in situ hybridization
-
Mobile, Alabama
- +279 more
Mar 5, 2015
S9910, Collecting and Storing Blood and Bone Marrow Samples From
Completed
- Leukemia
- +2 more
- biologic sample preservation procedure
-
Ft. Smith, Arkansas
- +291 more
Mar 5, 2015
Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- ruxolitinib phosphate
- +2 more
-
Birmingham, Alabama
- +23 more
Oct 22, 2014
Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
Completed
- Leukemia
- +2 more
- clonality analysis
- +2 more
-
Downey, California
- +95 more
Aug 4, 2014
Leukemia, MDS Trial in Australia, Canada, United States (asparaginase, cytarabine, gemtuzumab ozogamicin)
Completed
- Leukemia
- Myelodysplastic Syndromes
- asparaginase
- +3 more
-
Birmingham, Alabama
- +75 more
Feb 18, 2014